Lucas Ward
Stock Analyst at Ascendiant Capital
(1.25)
# 3,645
Out of 5,012 analysts
21
Total ratings
47.62%
Success rate
-19.13%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $3.73 | +141.29% | 3 | Oct 1, 2025 | |
| ACON Aclarion | Maintains: Buy | $20 → $22 | $7.90 | +178.66% | 4 | Sep 19, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $3.10 | +109.68% | 4 | Sep 9, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $7 → $3 | $1.45 | +106.90% | 3 | Sep 3, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $2.78 | +29.73% | 5 | Jun 16, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.48 | +182,332.43% | 2 | Jul 29, 2024 |
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $3.73
Upside: +141.29%
Aclarion
Sep 19, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.90
Upside: +178.66%
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $3.10
Upside: +109.68%
60 Degrees Pharmaceuticals
Sep 3, 2025
Maintains: Buy
Price Target: $7 → $3
Current: $1.45
Upside: +106.90%
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $2.78
Upside: +29.73%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.48
Upside: +182,332.43%